Journal article icon

Journal article

Direct and indirect costs of influenza-like illness treated with and without oseltamivir in 15 European countries: a descriptive analysis alongside the randomised controlled ALIC4E trial

Abstract:

Background and Objective

Influenza-like illness (ILI) leads to a substantial disease burden every winter in Europe; however, oseltamivir is not frequently prescribed to ILI patients in the primary-care setting. An open-label, multi-country, multi-season, randomised controlled trial investigated the effectiveness of oseltamivir for treating ILI in 15 European countries. We aimed to evaluate whether patients presenting with ILI in primary care and being managed with the ... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s40261-021-01057-y

Authors


More by this author
Role:
Author
ORCID:
0000-0002-1918-1791
More by this author
Role:
Author
ORCID:
0000-0001-5720-5291
More by this author
Role:
Author
ORCID:
0000-0002-9443-2837
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0001-5957-6280
More by this author
Role:
Author
ORCID:
0000-0002-4217-2869
More from this funder
Name:
European Commission's Seventh Framework Programme: Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE)
Grant:
HEALTH-F3-2013-602525
Publisher:
Springer
Journal:
Clinical Drug Investigation More from this journal
Volume:
41
Issue:
8
Pages:
685-699
Publication date:
2021-07-22
Acceptance date:
2021-06-20
DOI:
EISSN:
1179-1918
ISSN:
1173-2563
Pmid:
34292510
Language:
English
Keywords:
Pubs id:
1187977
Local pid:
pubs:1187977
Deposit date:
2021-09-24

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP